SV LIFE SCIENCES FUND IV, L.P.

CIK 1367381 · last filed 2019-04-10

SV LIFE SCIENCES FUND IV, L.P. is a corporate insider who has filed 6 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing shows the insider sold $5.8M of KALV on Apr 10, 2019. Across all open-market trades the lifetime net is −$83.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $39.1M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$39.15M

Companies

2

Total Filings

6

Lifetime Open-Market Net

-$83.85M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
KalVista Pharmaceuticals, Inc. (KALV) Delisted	10%+ Owner	1,698,554	$27.00	$45.86M	-$22.57M	3	2019-04-10
OCUL	10%+ Owner	4,364,130	$8.97	$39.15M	-$61.27M	2	2015-06-11

Recent Filings

6 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2019-04-10	KalVista Pharmaceuticals, Inc. (KALV) Delisted	Sell (S)	−200,000	-$5.84M	EDGAR
2019-03-28	KalVista Pharmaceuticals, Inc. (KALV) Delisted	Sell (S)	−498,700	-$14.38M	EDGAR
2019-01-02	KalVista Pharmaceuticals, Inc. (KALV) Delisted	Sell (S)	−117,408	-$2.35M	EDGAR
2015-06-11	OCUL	Sell (S)	−4,476,000	-$98.47M	EDGAR
2014-07-31	OCUL	Mixed	+31,027,284	$37.20M	EDGAR
2009-09-17	—	Sell (S)	−7,380,000	-$59.04M

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.